Cargando…
Mechanisms of thrombosis and cardiovascular complications in COVID-19
BACKGROUND: The novel coronavirus SARS-CoV-2, responsible for the 2019–2020 global (COVID-19) pandemic, is a respiratory virus associated with the development of thromboembolic complications and respiratory failure in severe cases. Increased risk of pulmonary embolism and thrombosis has been identif...
Autores principales: | Page, Eden M., Ariëns, Robert A.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813504/ https://www.ncbi.nlm.nih.gov/pubmed/33493983 http://dx.doi.org/10.1016/j.thromres.2021.01.005 |
Ejemplares similares
-
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
por: Ząbczyk, Michał, et al.
Publicado: (2023) -
Cardiovascular complications of COVID-19
por: Farshidfar, Farnaz, et al.
Publicado: (2021) -
Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
por: Yasmin, Farah, et al.
Publicado: (2023) -
Clot Structure and Fibrinolysis in Thrombosis and Hemostasis
por: Bagoly, Zsuzsa, et al.
Publicado: (2017) -
COVID-19-Associated Cardiovascular Complications
por: Lee, Clement C. E., et al.
Publicado: (2021)